Disciplined Investments’s Opko Health OPK Stock Holding History

Disciplined Investments’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	1675
2022 Q3	$0	Sell	1 -124	-99%	-$293	﹤0.01%	1503
2022 Q2	$0	Buy	125 +17	+16%	+$50	﹤0.01%	1519
2022 Q1	$0	Buy	+108	New	+$381	﹤0.01%	1541

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Disciplined Investments's OPK Position: Q4 2022 in Review

Disciplined Investments sold out of Opko Health (OPK) in Q4 2022, closing a stake of 1 share.

Disciplined Investments first reported a position in OPK in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 221 funds tracked by Wall St. Rank hold OPK as of Q4 2022.

Disciplined Investments reported no remaining Opko Health position as of Q4 2022 after selling out during the quarter.
Disciplined Investments sold 1 Opko Health share in Q4 2022.
Disciplined Investments first reported a position in Opko Health in Q1 2022 and held it in 3 quarters.
Disciplined Investments's Opko Health position peaked at $0 in Q3 2022.
221 funds tracked by Wall St. Rank held Opko Health as of Q4 2022.

Based on Disciplined Investments's 13F filing for Q4 2022, filed 2 Feb 2023.